These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3244611)

  • 1. An area function method for estimating the apparent absorption rate constant.
    Cheng H; Staubus AE; Shum L
    Pharm Res; 1988 Jan; 5(1):57-60. PubMed ID: 3244611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The area function method for assessing the drug absorption rate in linear systems with zero-order input.
    Cheng H; Jusko WJ
    Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of variation in drug elimination on five methods for assessing zero-order drug absorption rates.
    Cheng HY; Jusko WJ
    Pharm Res; 1990 Jan; 7(1):76-9. PubMed ID: 2300540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for calculating the mean absorption time of drugs undergoing reversible and first-pass metabolism.
    Cheng H; Shum L
    Biopharm Drug Dispos; 1993 Jan; 14(1):71-9. PubMed ID: 8427946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convolution-based approaches for in vivo-in vitro correlation modeling.
    Gillespie WR
    Adv Exp Med Biol; 1997; 423():53-65. PubMed ID: 9269483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An area function method for calculating the apparent elimination rate constant of a metabolite.
    Cheng HY; Jusko WJ
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):125-30. PubMed ID: 2715930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Area-based estimation of the initial volume of distribution and elimination rate constant following intravenous bolus injection.
    Khor SP; Johnson SL; Mayersohn M
    J Pharm Sci; 1991 Nov; 80(11):1042-50. PubMed ID: 1815055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of methyl parathion: a comparison following single intravenous, oral or dermal administration.
    Kramer RE; Wellman SE; Rockhold RW; Baker RC
    J Biomed Sci; 2002; 9(4):311-20. PubMed ID: 12145528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum entropy and its application to the calculation of drug absorption rates.
    Charter MK; Gull SF
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):645-55. PubMed ID: 3450847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of deflazacort in rabbits after intravenous and oral administration and its interaction with erythromycin.
    Escudero AI; Marín P; Cárceles CM; Escudero E
    J Vet Pharmacol Ther; 2018 Feb; 41(1):e10-e15. PubMed ID: 28741668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite.
    Piotrovskii VK
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):311-8. PubMed ID: 1875284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat.
    Nemes KB; Abermann M; Bojti E; Grézal G; Al-Behaisi S; Klebovich I
    J Pharm Pharmacol; 2000 Jan; 52(1):47-51. PubMed ID: 10716602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of pyrazinamide in plasma and CSF of rabbits following intravenous and oral administration.
    Chan K; Wong CL
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):195-9. PubMed ID: 3240765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.